Abbott's Medical Devices segment is the company's largest, generating a significant portion of total revenue. This segment focuses on developing and marketing a wide range of innovative medical devices for cardiovascular health, neuromodulation, diabetes care, and structural heart conditions. Research and development efforts are centered on creating minimally invasive technologies, advanced monitoring systems, and therapies that improve patient outcomes and quality of life. Key areas of focus include next-generation continuous glucose monitoring (CGM) systems, cardiac rhythm management devices, and innovative therapies for structural heart disease. Abbott's strong market position is driven by its commitment to technological innovation, clinical evidence, and strategic partnerships within the medical device industry. The company continues to invest in expanding its product portfolio and global reach to address unmet medical needs and drive future growth.

The Diagnostics segment at Abbott is dedicated to developing and delivering a broad range of diagnostic systems and tests for hospitals, laboratories, and point-of-care settings. This segment plays a crucial role in disease detection, monitoring, and management, enabling healthcare professionals to make informed decisions and improve patient care. Research and development efforts focus on advancing immunoassay, clinical chemistry, hematology, and molecular diagnostics technologies. Abbott's diagnostic solutions are used to detect infectious diseases, monitor chronic conditions, and personalize treatment strategies. The company's commitment to innovation and quality has established it as a leading provider of diagnostic solutions worldwide. Future opportunities include expanding its presence in emerging markets and developing new diagnostic tests for unmet medical needs.

Abbott's Nutritional Products segment develops and markets a wide range of science-based nutrition products for infants, children, and adults. This segment focuses on providing essential nutrients and dietary support to improve health and well-being across all stages of life. Research and development efforts are centered on developing innovative formulas, supplements, and medical nutrition products that address specific dietary needs and health conditions. Key product lines include infant formulas like Similac, pediatric nutrition products like Pedialyte, and adult nutrition products like Ensure and Glucerna. Abbott's commitment to scientific research and product innovation has established it as a trusted leader in the nutrition industry. Future opportunities include expanding its portfolio of personalized nutrition solutions and addressing the growing demand for healthy and convenient food options.

Abbott's Established Pharmaceutical Products segment focuses on providing high-quality, branded generic medicines to patients in emerging markets. This segment plays a crucial role in expanding access to affordable healthcare solutions and addressing unmet medical needs in developing countries. Research and development efforts are centered on developing new formulations, improving manufacturing processes, and expanding the therapeutic scope of its existing product portfolio. Key therapeutic areas include gastroenterology, women's health, cardiovascular health, and pain management. Abbott's commitment to quality and affordability has established it as a trusted provider of essential medicines in emerging markets. Future opportunities include expanding its geographic reach and developing new partnerships to further enhance access to healthcare in underserved populations.